Histological analysis of Spinal Cord Injury treated with Amniotic Membrane
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2025.222620Keywords:
Spinal cord injury, Amniotic membrane, Biomaterial, Healing, Regenerative medicineAbstract
Spinal cord injury (SCI) is one of the most harmful syndromes that affects humans due to neuronal destruction and interruption of the nerve impulse transmission between axons. The conduction of motor, sensory, and autonomic responses below the level of the injury is seriously compromised, generating high treatment costs for the health system and a reduction in quality of life, stimulating research into new treatment protocols. This study aimed to evaluate the effectiveness of a biomaterial, the amniotic membrane (AM), to treat experimentally induced SCI. 15 adult rats were divided into three groups (n = 5): S (Sham), L (SCI without treatment), and AM (SCI treated with AM). Spinal cord injury was induced in the region T9-T10 by direct trauma, free-falling a weight (10 g, 2 mm flat edge) held on a mini guillotine, 25 mm above the exposed spinal cord. A fragment of AM, obtained from the human placenta after maternal consent, was applied to the injured area only in the AM group. After 28 days, specimens from the area of spinal cord injury were excised and subjected to routine histological procedures. Data from the semi-quantitative score, obtained from a scheme that assigned different scores to regions of the spinal cord, and from the quantitative analysis were subjected to parametric statistical analysis. Results showed that Group S presented medullary tissue without changes (score 0). In contrast, Group L presented numerous areas of cavitation in the dorsal and lateral regions of the white and gray matter (9.61 ± 6.60 p<0.001) with an intense inflammatory infiltrate. The AM group exhibited small areas of cavitation in the dorsal and lateral regions of the white matter and part of the dorsal columns in the gray matter (0.94 ± 1,03, p<0.001), with few inflammatory cells. The results suggest the effectiveness of AM in the treatment of induced SCI, characterized by a reduction in the evolution of inflammatory and degenerative processes in the central nervous tissue compared to the untreated group.
Downloads
References
Shende P, Subedi M. Pathophysiology, Mechanisms and Applications of Mesenchymal Stem Cells for the Treatment of Spinal Cord Injury. Biomedicine and Pharmacotherapy 2017;91:693–706; doi: 10.1016/j.biopha.2017.04.126.
Ahuja CS, Wilson JR, Nori S, et al. Traumatic spinal cord injury. Nat Rev Dis Primers 2017;3:17018; doi: 10.1038/nrdp.2017.18.
Gazdic M, Volarevic V, Arsenijevic A, et al. Stem Cells and Labeling for Spinal Cord Injury. Int J Mol Sci 2017;18(1); doi: 10.3390/ijms18010006.
Zhang C, Rong W, Zhang GH, et al. Early electrical field stimulation prevents the loss of spinal cord anterior horn motoneurons and muscle atrophy following spinal cord injury. Neural Regen Res 2018;13(5):869–876; doi: 10.4103/1673-5374.232483.
Anjum A, Yazid MD, Daud MF, et al. Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms. Int J Mol Sci 2020;21(20):1–35; doi: 10.3390/ijms21207533.
Fouad K, Popovich PG, Kopp MA, et al. The Neuroanatomical–Functional Paradox in Spinal Cord Injury. Nat Rev Neurol 2021;17(1):53–62; doi: 10.1038/s41582-020-00436-x.
Pavlova V, Filipova E, Uzunova K, et al. Pioglitazone Therapy and Fractures: Systematic Review and Meta- Analysis. Endocr Metab Immune Disord Drug Targets 2018;18(5):502–507; doi: 10.2174/1871530318666180423121833.
Hachem LD, Fehlings MG. Pathophysiology of Spinal Cord Injury. Neurosurg Clin N Am 2021;32(3):305–313; doi: 10.1016/j.nec.2021.03.002.
Karsy M, Hawryluk G. Modern Medical Management of Spinal Cord Injury. Curr Neurol Neurosci Rep 2019;19(9); doi: 10.1007/s11910-019-0984-1.
Cofano F, Boido M, Monticelli M, et al. Mesenchymal Stem Cells for Spinal Cord Injury: Current Options Limitations, and Future of Cell Therapy. Int J Mol Sci 2019;20(11); doi: 10.3390/ijms20112698.
Silini AR, Magatti M, Cargnoni A, et al. Is Immune Modulation the Mechanism Underlying the Beneficial Effects of Amniotic Cells and Their Derivatives in Regenerative Medicine? Cell Transplant 2017;26(4):531–539; doi: 10.3727/096368916X693699.
Fénelon M, Catros S, Meyer C, et al. Applications of Human Amniotic Membrane for Tissue Engineering. Membranes (Basel) 2021;11(6); doi: 10.3390/membranes11060387.
Mamede KM, Sant’Anna LB. Antifibrotic effects of total or partial application of amniotic membrane in hepatic fibrosis. An Acad Bras Cienc 2019;91(3); doi: 10.1590/0001-3765201920190220.
Faramarzi M, Kaboodkhani R, Roosta S, et al. Application of amniotic membrane for covering mastoid cavity in canal wall down mastoidectomy. Laryngoscope 2019;129(6):1453–1457; doi: 10.1002/lary.27638.
Nicodemo M de C, das Nevesii LR, Aguiar JC, et al. Amniotic membrane as an option for treatment of acute Achilles tendon injury in rats. Acta Cir Bras 2017;32(2):125–139; doi: 10.1590/s0102-865020170205.
Arrizabalaga JH, Nollert MU. Human Amniotic Membrane: A Versatile Scaffold for Tissue Engineering. ACS Biomater Sci Eng 2018;4(7):2226–2236; doi: 10.1021/acsbiomaterials.8b00015.
Shaw KA, Parada SA, Gloystein DM, et al. The Science and Clinical Applications of Placental Tissues in Spine Surgery. Global Spine J 2018;8(6):629–637; doi: 10.1177/2192568217747573.
Walkden A. Amniotic Membrane Transplantation in Ophthalmology: An Updated Perspective. Clinical Ophthalmology 2020;14:2057–2072; doi: 10.2147/OPTH.S208008.
Duerr RA, Ackermann J, Gomoll AH. Amniotic-Derived Treatments and Formulations. Clin Sports Med 2019;38(1):45–59; doi: 10.1016/j.csm.2018.08.002.
Santos J de AF, Nicolau RA, Sant’Anna LB, et al. Diabetic Foot Wounds Treated With Human Amniotic Membrane and Low-level Laser Therapy: A Pilot Clinical Study. Wound Manag Prev 2021;67(8):16–23; doi: 10.25270/wmp.2021.8.1623.
Marsh KM, Ferng AS, Pilikian T, et al. Anti-inflammatory properties of amniotic membrane patch following pericardiectomy for constrictive pericarditis. J Cardiothorac Surg 2017;12(1); doi: 10.1186/s13019-017-0567-7.
Pogozhykh O, Prokopyuk V, Figueiredo C, et al. Placenta and Placental Derivatives in Regenerative Therapies: Experimental Studies, History, and Prospects. Stem Cells Int 2018;2018; doi: 10.1155/2018/4837930.
Leal-Marin S, Kern T, Hofmann N, et al. Human Amniotic Membrane: A Review on Tissue Engineering, Application, and Storage. J Biomed Mater Res B Appl Biomater 2021;109(8):1198–1215; doi: 10.1002/jbm.b.34782.
Nejad AR, Hamidieh AA, Amirkhani MA, et al. Update review on five top clinical applications of human amniotic membrane in regenerative medicine. Placenta 2021;103:104–119; doi: 10.1016/j.placenta.2020.10.026.
Sant’Anna LB, Brito FS, Barja PR, et al. Long-term effects of human amniotic membrane in a rat model of biliary fibrosis. Brazilian Journal of Medical and Biological Research 2017;50(7); doi: 10.1590/1414-431X20175692.
Nicodemo M de C, Das Neves LR, Aguiar JC, et al. Amniotic membrane as an option for treatment of acute achilles tendon injury in rats. Acta Cir Bras 2017;32(2):125–139; doi: 10.1590/s0102-865020170205.
Falavigna A, Cechetti F, Finger G, et al. Experimental Model of Spinal Cord Injury (Sci) in Rats: Management Guidelines. 2013.
Paula AA, Nicolau RA, Lima M de O, et al. “Low-intensity laser therapy effect on the recovery of traumatic spinal cord injury.” Lasers Med Sci 2014;29(6):1849–1859; doi: 10.1007/s10103-014-1586-4.
Kjell J, Olson L. Rat Models of Spinal Cord Injury: From Pathology to Potential Therapies. DMM Disease Models and Mechanisms 2016;9(10):1125–1137; doi: 10.1242/dmm.025833.
Shen H, Fan C, You Z, et al. Advances in Biomaterial-Based Spinal Cord Injury Repair. Adv Funct Mater 2022;32(13); doi: 10.1002/adfm.202110628.
Huang L, Fu C, Xiong F, et al. Stem Cell Therapy for Spinal Cord Injury. Cell Transplant 2021;30; doi: 10.1177/0963689721989266.
Moraes JTGDO, Costa MM, Alves PCS, et al. Effects of Preservation Methods in the Composition of the Placental and Reflected Regions of the Human Amniotic Membrane. Cells Tissues Organs 2021;210(1):66–76; doi: 10.1159/000515448.
Fu H, Zhao Y, Hu D, et al. Depletion of microglia exacerbates injury and impairs function recovery after spinal cord injury in mice. Cell Death Dis 2020;11(7); doi: 10.1038/s41419-020-2733-4.
Gao L, Peng Y, Xu W, et al. Progress in Stem Cell Therapy for Spinal Cord Injury. Stem Cells Int 2020;2020; doi: 10.1155/2020/2853650.
Xu H, Zhang J, Tsang KS, et al. Therapeutic Potential of Human Amniotic Epithelial Cells on Injuries and Disorders in the Central Nervous System. Stem Cells Int 2019;2019; doi: 10.1155/2019/5432301.
Moraes JTGDO, Costa MM, Alves PCS, et al. Effects of Preservation Methods in the Composition of the Placental and Reflected Regions of the Human Amniotic Membrane. Cells Tissues Organs 2021;210(1):66–76; doi: 10.1159/000515448.
Zhou HJ, Wang LQ, Xu QS, et al. Downregulation of miR-199b promotes the acute spinal cord injury through IKKβ-NF-κB signaling pathway activating microglial cells. Exp Cell Res 2016;349(1):60–67; doi: 10.1016/j.yexcr.2016.09.020.
Ryu HH, Kang BJ, Park SS, et al. Comparison of Mesenchymal Stem Cells Derived from Fat, Bone Marrow, Wharton’s Jelly, and Umbilical Cord Blood for Treating Spinal Cord Injuries in Dogs. Journal of Veterinary Medical Science 2012;74(12):1617–1630; doi: 10.1292/jvms.12-0065.
Neves MF, Fonseca JLR, Carvalho PCS, et al. Analysis of Movements in Spinal Cord Hemisection Treatment with Amniotic Membrane – Preclinical Study. Asian Journal of Physical and Chemical Sciences 2022;28–37; doi: 10.9734/ajopacs/2022/v10i130148.
Kroner A, Rosas Almanza J. Role of Microglia in Spinal Cord Injury. Neurosci Lett 2019;709; doi: 10.1016/j.neulet.2019.134370.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Débora Campos Chaves Chaves, Leonardo Borges de Lima, Luciana Barros Sant'Anna, Mario Oliveira Lima, Emilia Angela Loschiavo Arisawa
This work is licensed under a Creative Commons Attribution 4.0 International License.
